Knowledge and awareness of the general public and perception of pharmacists about antibiotic resistance by Mason, Thuy et al.
RESEARCH ARTICLE Open Access
Knowledge and awareness of the general
public and perception of pharmacists
about antibiotic resistance
Thuy Mason, Claire Trochez, Remmya Thomas, Maria Babar, Iman Hesso and Reem Kayyali*
Abstract
Background: Antibiotic resistance (AR) continues to be a serious problem. Many factors contribute to AR, including
inappropriate use of antibiotics, in which both healthcare professionals and patients play a contributing role. This
study aimed to assess the awareness and knowledge of antibiotic usage and AR among the general public (in
affluent and deprived areas) and community pharmacists’ (CPs’) in Greater London.
Methods: A cross-sectional survey involving members of the public was conducted between July 2014 and
February 2015. Stage one involved members of the public (N = 384) residing in affluent areas of London. The
second stage targeted public (N = 384) in deprived areas of London. In addition, CPs (N = 240) across the same
areas were also surveyed. Data analysis was performed using Microsoft Excel and SPSS Software packages.
Results: Response rate: 36% (n = 139/384) and 57% (n = 220/384) and 25% (n = 60/240) of public residing in
affluent areas, deprived areas and of CPs respectively was achieved. Definitive trends in knowledge of how
antibiotics work could not be drawn to distinguish between affluent and deprived areas. However, public
respondents residing in affluent areas possessed better understanding of AR and prudent use of antibiotics, and
this was statistically significant in both cases (p < 0.05). Exposure to an antibiotic campaign (32% in affluent areas,
17% in deprived areas) did not raise public respondents’ knowledge on AR and only partially raised their general
knowledge on antibiotics usage. Only 20% of public residing in deprived areas received counselling from a CP,
among them 74% had an antibiotic prescribed on at least one previous occasion. Those who received counselling
displayed better knowledge about concordance/adherence with respect to antibiotic usage (p < 0.05) whereas
exposure to an antibiotic campaign made no significant impact on knowledge about concordance/adherence.
Conclusion: The study highlights that there has been no change in the status quo with respect to awareness of
antibiotic usage and AR even after the implementation of several awareness campaigns in England. Those who
benefited from CP counselling showed a significant better knowledge towards prudent antibiotic usage which
stresses the importance of CPs’ counselling on antibiotic prescription.
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Background
Alexander Fleming, the man who discovered penicillin
in 1928, and who subsequently received his Nobel Prize
in 1945 for this work, predicted in his then winning
speech that the world would one day be facing antibiotic
resistance (AR) [1–5]. Indeed his prediction has now be-
come a reality [2], as the whole world is heading towards
a “post-antibiotic era” [6].
Several factors play a contributing role in the develop-
ment of AR. While inappropriate use of antibiotics has
been identified as the main cause behind AR [7, 8]; there
are still other causes for it including the use of antibi-
otics in the food production industry and in animals’
health making them key reservoirs of antibiotic resistant
bacteria [9, 10].
Both healthcare professionals (HCPs) and patients are
responsible for AR; there is a direct correlation between
use and overuse of antibiotics and the emergence of AR
[7, 11, 12]. In the case of HCPs, it is most likely due to
inappropriate prescribing. In the case of patients, it is
most likely because of overusing or not taking a full
course of treatment; or self-medication by sharing medi-
cation with other people, or keeping part of the course
for another occasion or acquisition from pharmacies
without a prescription [8, 13]. Therefore, ensuring ap-
propriate use of antibiotics is crucial to enable resistance
to be reduced [8, 14]. In Europe, the tremendous burden
of AR was estimated to be €1.5 billion annually incorp-
orating healthcare costs and productivity losses [15–18].
In the UK, more than 40 million prescriptions are issued
for antibiotics every year, costing the National Health
Service (NHS) £192 m [19). In return, another research
within the UK highlighted that 1 in 4 antibiotic prescrip-
tions are unnecessarily prescribed, equating to a total of
10 million unnecessary prescriptions each year [19].
The threat of AR is increasing at an alarming rate [14],
making simple infections untreatable or routine medical
procedures almost impossible in the near future [20]. The
magnitude of the threat of AR has been reported to be
comparable to that of climate change [21]. AR has been
widely acknowledged as a global public health issue and a
global challenge [6, 9, 12, 14, 19], that leads to increased
healthcare costs, rise in new adverse reactions to antibiotics
and increased mortality [6, 8]. Estimates indicate an average
death toll of 25,000 people each year in Europe due to
antibiotic-resistant bacteria [16–18, 21]. This highlights the
need for an urgent response from every corner of the globe
to strengthen measures to combat AR [21–23].
AR would not be such a great concern if there were a
continuous supply of new novel antibiotics. Since
pharmaceutical companies have not been forthcoming
with development of any new antibiotics with novel
mechanisms of action in recent years [24–27], efforts
have been made to reduce the rate and stem the extent
of AR by raising awareness in the community at large
and targeting the public specifically.
Global collaboration to encourage the prudent use of
antibiotics and raise awareness of AR has been promoted
through awareness-raising activities/ campaigns in
Australia, USA,Canada and most European countries [14,
28]. In 1999, the Department of Health in England had
attempted to invest in campaigns like ‘Andybiotic – Don’t
wear me out’ [29] in which the awareness was raised. A
survey conducted in 2003 revealed that awareness of the
campaign was low and 43% (p < 0.0005) of the people still
believed that antibiotics work on viruses [30]. Campaigns
such as the European Antibiotic Awareness Day (EAAD)
introduced in 2008, focused on educating the general pub-
lic about AR and promoting the sensible use of antibiotics
as well as taking measures to reduce the risk of infections
e.g. maintaining good hygiene [28]. The campaign also en-
couraged prescribers to prescribe wisely, providing tools
like a checklist that can be used to optimise antibiotic pre-
scribing [31]. McNulty et al. [32] compared attitudes to-
wards antibiotics usage of members of the public before
(n = 1888) and after (n = 1830) the EAAD campaign to
evaluate its success. No improvement was seen in the re-
spondents’ understanding of correct antibiotics usage.
Furthermore, the results detected a significant rise in the
number of respondents keeping leftover antibiotics and
thus casting doubt over the evidence that the campaign
was effective [32].
This demonstrates the fact that one campaign at a
point in time does not sufficiently promote the aware-
ness amongst the general public. There is a need for
continual public awareness campaigns covering large
percentages of the public. As part of the EAAD, in Sep-
tember 2014, the Antibiotic Guardian Campaign was
launched in England where all members of the society,
including HCPs are asked to make a pledge that encour-
ages the individual to take on measures that combat
antimicrobial resistance [33].
HCPs such as community pharmacists (CPs) are in the
best position to help in reducing AR due to their level of
antibiotic knowledge and accessibility to the community
[34, 35]. This can be done by providing counselling to
patients about antibiotics prescriptions, particularly dos-
age intervals, side effects and interactions with other
medications or food, given that 80% of antibiotics are
prescribed in primary care [29, 36]. In England, CPs are
expected to provide counselling about medications as
part of their contractual framework through essential
services such as dispensing to ensure patients’ safe use
of their medicines [37]. In addition, the minor ailment
scheme in England has been commissioned through CPs
as part of their contractual framework as an enhanced
service to aid general practitioners (GPs) with winter
pressures [38]. The scheme has been introduced so that
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CPs can provide advice and support about the manage-
ment of minor ailments including coughs, colds, sore
throats and earaches [39], through which antibiotics can
be potentially prescribed unnecessarily, without the need
to visit the GP practice [39].
This study aimed to assess the awareness and know-
ledge of antibiotic usage and AR among the general pub-
lic and to assess CPs’ knowledge about AR in London.
The study was conducted among public residing in afflu-
ent and deprived areas, with a hypothesis that such a
socio-demographic factor can be related to awareness
and knowledge of AR, with public in affluent areas hav-
ing more awareness and knowledge of AR, since the in-
cidence of infectious diseases tends to be higher in
groups with lower socioeconomic status and outcomes
tend to be poorer [40].
Methods
This is a cross-sectional survey study that was con-
ducted in two stages. Stage one involved members of the
public in affluent areas, whereas stage two involved
members of the public in deprived areas, in addition to
CPs in both affluent and deprived areas.
Public survey
Members of the public were approached in person by
two researchers in affluent public areas of London
(Wimbledon, Richmond and Kingston upon Thames),
and another two researchers in deprived public areas or
in areas with diverse ethnicities (Hackney, Waltham For-
est, City of Westminster, Haringey, Newham, Islington,
Enfield). Affluent and deprived areas were determined
based on the latest published index of multiple depriva-
tions (IMD) score [41] and were chosen due to conveni-
ence based on proximity to the researchers but the
distribution of the questionnaires was randomized.
A sample size of 384 members of the public in affluent
areas and 384 in deprived areas were approached at random
in public places and handed the questionnaire. The total
adult population in the included boroughs was 327,078 and
1,196,845 for affluent and deprived areas respectively. The
sample size calculation was done using Raosoft sample size
calculator [42] providing a confidence level of 95% with mar-
gin of error of 5%, which indicated the need to approach 384
in affluent and deprived areas. Members of the public were
included in the study if they were: between 18 and 65 years,
able to read and understand English to enable them
complete the questionnaire and willing to participate. Those
who consented to participate filled out and handed the ques-
tionnaire back to the researchers. Data was collected be-
tween July 2014 and February 2015.
The questionnaire was structured to facilitate
self-administration by the public, and was partially based
on a previous survey related to the topic [43] and aimed
to collect data about public attitudes, knowledge and
awareness levels of AR, as well as exposure to an anti-
biotic awareness campaign through TV, radio, GP sur-
geries or pharmacies. The second stage survey for the
public residing in deprived areas had an additional ques-
tion about whether they received counselling about anti-
biotic usage once prescribed to them. Both surveys
consisted mostly of close-ended questions, some Likert
scale questions and multiple response questions with
one or two open-ended questions at the end to enable
participants the freedom of expression in answering .
CP survey
240 Pharmacies were selected by convenience sampling
in the same areas through which public were
approached. The sample size was also calculated using
the Raosoft sample size calculator [42]. The total num-
ber of pharmacies in the included boroughs in the study
is 612 (32 Kingston, 82 Sutton and Merton including
Wimbledon, 45 Richmond, 94 Westminster, 63 Waltham
forest,65 Hackney, 57 Haringey, 68 Newham, 45 Isling-
ston, 61 Enfield) [44]. Therefore, the total sample size
calculated for the included boroughs was 237 at a 95%
confidence level and 5% margin of error.
CPs were sent a postal survey with a prepaid envelope
for returning the questionnaire in January 2015. The ques-
tionnaire was posted with an information sheet detailing
the aims of the study, maintenance of confidentiality and
the importance of participation. Only one response was
received from each pharmacy. To maximise response rate,
a follow-up questionnaire package was sent to CPs who
didn’t provide an initial response, after one month in Feb-
ruary 2015. Only fully completed questionnaires that were
returned up until end of February 2015 were considered
for the final analysis.
The questionnaire for this phase was designed by the
researchers and focused on the role CPs played in in-
creasing awareness about AR and whether they feel
there is a need to do more for the community in this
regard.
Pilot study
A pilot study was done to validate both CPs and public
questionnaires after obtaining ethical approval and prior
data collection.
For CP survey, the pilot phase aimed to test content
and face validity of the questionnaire used. The re-
searchers discussed the questionnaire topics informally
with 5 CPs in South London. Afterwards, the CPs were
asked to fill the questionnaire and provide any com-
ments about the questions on the chosen topics. The
content was deemed satisfactory by the CPs; however,
minor changes were required, which involved changing
the wording of some questions.
Mason et al. BMC Public Health  (2018) 18:711 Page 3 of 10
Whereas the public survey was piloted on a sample of
30 members of the public in South London to test for
face and content validity. People were asked to fill the
questionnaire, to indicate whether the questions were
clear in relation to the topic and to provide any com-
ments to improve the questionnaire. Minor amendments
were required which involved changing the wording of
some questions in order to facilitate self-administration.
The results obtained in the pilot study were not included
in the final analysis to avoid any type of bias.
Data analysis
All responses were coded before analysis. Simple statis-
tical analyses (Chi square test) were employed to deter-
mine whether a relationship exists between responses to
questions on knowledge, behaviour and respondents’
demographics. A p value of < 0.05 was considered to be
statistically significant.
Ethical consideration
Ethical approval for both stages of the study was ob-
tained from the Delegated Research Ethics Committee at
Kingston University London (Ref: 1213/045).
Results
A total of 384 members of the public were approached
in affluent areas and 139 agreed to participate giving a
response rate of 36%. Whereas, in deprived areas, 384
were approached and 220 agreed to participate, giving a
response rate of 57%. As for CPs, 240 questionnaires
were mailed; however only 60 completed the question-
naire, providing a response rate of 25%.
General knowledge on antibiotics usage and on
antibiotics resistance possessed by respondents in
affluent and deprived areas
Table 1 shows that definitive trends in knowledge of
how antibiotics work cannot be drawn to distinguish be-
tween affluent and deprived areas. 81% (n = 112/139) of
respondents in affluent areas displayed better under-
standing by disagreeing with the statement ‘antibiotics
help cure the common cold, cough and flu’ compared
with 45% (n = 98/220) in deprived areas (p < 0.05).
Whereas, 68% (n = 149/220) of respondents in deprived
areas displayed better understanding by disagreeing with
the statement ‘antibiotics are effective against fungi’ com-
pared with 43% (60/139) in affluent areas (p < 0.05). Both
sets of respondents possessed comparatively poor know-
ledge as only 55% (n = 77/139) in affluent areas and 46%
(n = 101/220) in deprived areas knew that antibiotics are
not effective against virus.
As for knowledge on issues surrounding AR, Table 2
shows that respondents in affluent areas exhibited a much
better understanding on the subject, where 81% (n = 112/
139) correctly agreed that ‘antibiotic resistance is when an-
tibiotics no longer work to treat infections’, compared to
57% (n = 126/220) in deprived areas, (p < 0.05) and 88%
(n = 123/139) agreed that ‘if taken too often or unnecessar-
ily, antibiotics are less likely to work in the future’, com-
pared to 61% (n = 135/220) in deprived areas, (p < 0.05).
Knowledge on prudent antibiotics usage of respondents
in affluent and deprived areas
Respondents in affluent areas showed a much better un-
derstanding on prudent antibiotics usage compared to
those in deprived areas (Table 3), with 99% always ‘tak-
ing antibiotics as prescribed’ and 85% never ‘stopped tak-
ing antibiotics when symptoms have improved’, compared
to 58% (n = 95/163) and 34% (n = 55/163) respectively in
deprived areas (p < 0.05).
Demographic factors, counselling and campaign exposure
impact on the knowledge and behaviour of respondents
in deprived areas
The responses provided by respondents in deprived
areas were further analysed.
Ethnicity and language did not influence their general
knowledge on antibiotic usage whereas education (at a
degree level or above), being in a healthcare profession
or having a family member working in healthcare partly
Table 2 Respondents’ knowledge surrounding antibiotic
resistance (AR) in affluent and deprived areas
STATEMENTS (correct response) Affluent
Areas % (n)
% = n/N
(N = 139)
Deprived
Areas % (n)
% = n/N
(N = 220)
x2
p
Antibiotic resistance is when
antibiotics no longer work
to treat infections (agree)
81 (112) 57 (126) x2 = 20.7008
p < 0.05
If taken too often or
unnecessarily, antibiotics are
less likely to work in the
future (agree)
88 (123) 61 (135) x2 = 30.9991
p < 0.05
Table 1 Awareness of respondents in affluent and deprived
areas on correct antibiotic usage
STATEMENTS (correct response) Affluent
Areas % (n)
% = n/N
(N = 139)
Deprived
Areas % (n)
% = n/N
(N = 220)
x2
p
Antibiotics help cure the
common cold, cough and flu
(disagree)
81 (112) 45 (98) x2 = 45.5467
p < 0.05
Antibiotics are effective against
fungi (disagree)
43 (60) 68 (149) x2 = 21.1259
p < 0.05
Antibiotics are effective against
viruses (disagree)
55 (77) 46 (101) x2 = 3.0666
p = 0.079918
Antibiotics are effective against
bacteria (agree)
80 (111) 78 (171) x2 = 0.2291
p = 0.632171
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enhanced but not always significantly, their general
knowledge on antibiotic usage (Table 4).
In affluent areas, only 32% (n = 45/139) of respondents
have been exposed to an antibiotic awareness campaign
compared to an even lower 17% (n = 37/220) of respon-
dents in deprived areas. Exposure to an antibiotic aware-
ness campaigns in deprived areas partially raised public
respondents’ general knowledge on antibiotics usage but
not on AR (Tables 4 and 5a).
The responses of public in deprived areas who have had
an antibiotic prescribed to them on at least one previous
occasion (n = 163/220) were further analysed to investi-
gate the impact of counselling and antibiotic campaigns
on their antibiotic consumption behaviour (Table 5b).
However, only 20% (n = 32/163) stated that they always re-
ceived counselling on antibiotic usage. Respondents who
received counselling on antibiotic usage displayed better
knowledge about concordance/adherence behaviour with
respect to antibiotic usage than those who did not always
receive counselling (p < 0.05) (Table 5b). Exposure to an
antibiotic campaign made no significant impact on re-
spondents’ knowledge about concordance/adherence be-
haviour with respect to antibiotic usage (Table 5b).
Response on whether antibiotics had been obtained by
participants without a prescription
In affluent areas, 96% (n = 134/139) participants recalled
that they have had an antibiotic on at least one previous
occasion, 92% (n = 123/134) confirmed the antibiotics
were prescribed to them on a prescription. However, 5%
(n = 7/134) of respondents admitted they had some anti-
biotics left over from a previous supply and 1% (n = 1/
134) indicated the supply was purchased over the coun-
ter (OTC). None of the respondents indicated that
friends/family had given them antibiotics, however 3%
(n = 4/134) specifically requested their doctor to pre-
scribe an antibiotic but were refused.
In deprived areas, 74% (n = 163/220) of respondents
recalled that they have had antibiotics on at least one
previous occasion. 90% (n = 146/163) confirmed the
antibiotics were prescribed to them on a prescription.
However, some participants also admitted that they had
obtained antibiotics from various other means. Notably
12% (n = 19/163) from family/friends, 7% (n = 12/163)
from abroad, 9% (n = 14/163) from a ‘previous supply’,
and 7% (n = 11/163) from the internet.
Interestingly, 75% (n = 45/60) of pharmacist respon-
dents indicated they had been requested to supply an
antibiotic without a prescription. The main requests for
antibiotics were for cold/flu (64%, n = 29/45) followed
by for sore throat (24%, n = 11/45).
Relationship of the sampled general public and their
prescriber
In affluent areas, 73% (n = 101/139) of participants indi-
cated they would never insist on having an antibiotic
prescribed to them. However, only 33% (n = 46/139) said
they would trust their doctor if an antibiotic was ever re-
fused to be prescribed to them. Whereas, in deprived
areas, 66% (n = 108/163) of participants who had an
antibiotic on at least one previous occasion indicated
they hadn’t insisted on having an antibiotic prescribed to
them. When asked whether they would trust their doc-
tor even if they did not prescribe them an antibiotic, al-
though 36% (58/163) remained neutral, 21% (35/163)
indicated that they would strongly distrust their doctor
if an antibiotic is not prescribed.
Level of engagement of CPs in raising AR awareness
amongst the general public
80% (n = 48/60) of CPs admitted to not ever initiate a
campaign to raise awareness on AR although 81%
(n = 49/60) agreed with the importance of running the
campaigns. The reported low uptake of pharmacist
respondents in running the antibiotic awareness
campaign was due to several factors. Notably lack of
engagement was cited to be due to lack of funding (60%,
n = 36/60), high workload/time constraints (58%, n = 35/
60), followed by language barrier with patients/commu-
nication problems (53%, n = 32/60).
Discussion
The current findings shed light on the existing situation
pertaining to antibiotic usage and awareness of AR
among the public in affluent and deprived areas of
London.
Overall, public respondents residing in affluent areas
possessed much better knowledge and understanding on
AR problems and antibiotic usage and this was statisti-
cally significant (p < 0.05), which in return supports our
hypothesis. In addition, public respondents in deprived
areas possessed much poorer knowledge on prudent
antibiotic usage compared to those in affluent areas
(p < 0.05). In the current study, 88% in affluent areas
Table 3 Knowledge on prudent antibiotics usage of
respondents in affluent and deprived areas
STATEMENTS (correct response) Affluent
Areas % (n)
% = n/N
(N = 134)
Deprived
Areas % (n)
% = n/N
(N = 163)
x2
p
Following instructions/taking
antibiotics as prescribed is
important (always)
99 (133) 58 (95) x2 = 69.2196
p < 0.05
Stop taking antibiotics
when symptoms have
improved (never)
85 (114) 34 (55) x2 = 79.0194
p < 0.05
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agreed that antibiotics become ineffective if used un-
necessarily compared to 61% in deprived areas. In this
regard, a recent report by the European commission
demonstrated that knowledge of antibiotics among the
public has remained constant since 2013 with 84% of
participants knew that antibiotics would become inef-
fective if used unnecessarily [45]. Nevertheless, the
current results are also comparable to those reported by
McNulty et al. [29], 10 years ago, which in return still
highlights the lack of improvement in public knowledge
about AR and the need to improve the status quo.
Although public respondents in both affluent and de-
prived areas were equally knowledgeable (80 and 78% re-
spectively) that antibiotics are effective against bacteria,
they could not differentiate between bacteria and viruses
and hence, believed that antibiotics would work against
diseases caused by viruses also. Our results showed that
45 and 54% in affluent and deprived areas respectively
believed that antibiotics are effective against viruses. Un-
fortunately, this is again comparable to the results of the
survey study that was conducted in Britain10 years ago
by McNulty et al. [29] after the Andybiotic campaigns in
1998 and 2002, where 43% (3062/7120) of population
believed that antibiotics can kill viruses. This in return
calls into question the success of the antibiotic aware-
ness campaigns as it highlights that any efforts to date
to educate the general public have not made a remark-
able impact on this front. In the current study, exposure
to the antibiotic awareness campaigns did not enrich
knowledge of those respondents on how to take an anti-
biotic correctly, as the responses did not differ statisti-
cally to those who had not been exposed to campaigns.
In deprived areas, 55% of respondents incorrectly
believed that antibiotics can treat sore throat, cure
Table 5 Impact of counselling and antibiotic awareness campaign on AR and concordance/adherence in deprived areas
a Respondents’ knowledge on Antibiotic Resistance
STATEMENTS (correct response) CAMPAIGN EXPOSURE % (n)
% = n/N
Yes
N = 37
No
N = 183
Bacteria has potential to become resistant to antibiotics
(strongly agree/agree)
73 (27) 69 (126)
x2
p
0.2467
0.619391
Antibiotic resistance is when antibiotics no longer work to treat infections
(strongly agree/agree)
54 (20) 63 (115)
x2
p
1.0024
0.316725
If taken too often or unnecessarily, antibiotics are less likely to work in the
future (strongly agree/agree)
62 (23) 56 (103)
x2
p
0.4345
0.509766
b Concordance/adherence behaviour of respondents in deprived areas who have had an antibiotic prescribed on at least one previous occasion
STATEMENTS (correct response) Campaign exposure % (n)
% = n/N
Counselling exposure % (n)
% = n/N
Yes
N = 33
No
N = 130
Always
N = 32
Not always/Sometimes/never
N = 131
Do you follow the instructions given to take an antibiotic? (always) 64 (21) 57 (74) 84 (27) 52 (68)
x2
p
0.4878
0.48489
11.1494
0.000841
Do you complete the full course of antibiotics prescribed? (always) 45 (15) 46 (60) 75 (24) 39 (51)
x2
p
0.0052
0.942617
13.4687
0.000243
Do you stop taking the antibiotics once you start feeling better? (never) 27 (9) 35 (46) 59 (19) 27 (36)
x2
p
0.7746
0.378784
11.7015
0.000624
Do you skip doses of antibiotics? (never) 33 (11) 33 (43) 56 (18) 27 (36)
x2
p
0.0008
0.977704
9.6082
0.001937
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common cold, cough and flu; 34% also admitted that
they had insisted that an antibiotic be prescribed to
them. In addition, CPs in the current study indicated
that cold/flu and sore throat were the main conditions
for which people request antibiotics from a pharmacy
without prescription. Patients demand antibiotics perhaps
because they often misunderstand the antibiotic action
against microbes and the different models of prudent
usage. In a UK study, 55% of 1000 GPs surveyed admitted
that they felt under pressure from patients demanding an
antibiotic. Importantly, 44% revealed that although they
felt an antibiotic was neither appropriate nor necessary,
they prescribed it anyway to close the consultation with
the patient [46]. In another survey in England, 5 out of 6
GPs reported to feel pressured to prescribe an antibiotic
when it is not necessary [38]. Physicians are more likely to
prescribe antibiotics under pressure in order to meet the
patient’s expectation and satisfaction [38, 46, 47]. In our
survey, 67% of respondents in affluent areas and 21% in
deprived areas indicated that they would distrust their
doctor if their request for an antibiotic is refused.
Considering that 80% of prescribed antibiotics occur
in primary care [29, 36, 48], CPs can play a potential role
in counselling their patients [38]. In the current study,
participants in deprived areas who received counselling
displayed a statistically significant better understanding
on how to correctly take an antibiotic, so it is disap-
pointing to see that under 20% (n = 32/163) in deprived
areas actually received counselling on antibiotic usage
from a CP, given that counselling on safe use of medi-
cines is a part of the dispensing service which is pro-
vided by all pharmacy contractors with NHS England
[37]. On the other hand, this highlights the importance
of CPs in this field and comes in line with previous calls
in England for CPs to become “antibiotic guardians” as
one way to halt the spread of AR [38].
In the current study, although 81% of CPs indicated
that AR awareness campaigns are important to educate
members of the public, yet their motivation in running
such campaigns is lacking, with 80% not ever initiating
an antibiotic awareness campaign. This was reflected
with the small percentages of the public who were ex-
posed to an antibiotics awareness campaign (32 and 17%
in affluent and deprived areas respectively). However,
this highlights/suggests lack of CPs’ efforts for curtailing
the global crisis of AR, and stresses the importance to
have joint efforts by all HCPs and members of the public
to address the issue of AR [38].
A small percentage of respondents admitted to taking
antibiotics that were not prescribed for them by a quali-
fied HCP. The revelation by some respondents that they
have leftover antibiotics (5% in affluent areas and 9% in
deprived areas) was similar to the 10% of those surveyed
in other studies [49, 50]. In our survey, this inappropriate
behaviour is marginally less yet struck a chord with that
conducted by Pechère et al. [51] which reported that the
public held inaccurate belief about the appropriate usage
of antibiotics with 62% keeping leftover antibiotics for
future use. Pechere [52] noted that patients frequently
report discontinuing antibiotic therapy when they begin to
feel better which might be the very reason why they would
have leftover antibiotics. The implication of keeping
leftover antibiotics, besides being an indicator of poor
compliance with antibiotic therapy [53], has been widely
accepted as being a contributing factor to AR [8, 53], but
the potential three-fold impact on AR has not yet been
fully realised. Firstly, stopping the antibiotic too soon is
likely to allow bacteria to proliferate leading to AR.
Secondly, the left over antibiotics may not be suitable for
the next infection and thirdly, even if they were suitable,
the amount left over is unlikely to be sufficient for the
desired treatment duration [53]. This depicts the need for
creating public awareness that antibiotics should only be
used with a valid prescription and demands appropriate
counselling on finishing the course as prescribed to ensure
that the effectiveness of antibiotics is preserved [2, 53].
Although, this latter matter is currently under debate [54].
Communication between HCPs and their patients
should play an important part in conveying correct
usage of antibiotics to reduce AR. Horne [55]
highlighted the importance of patient-provider interac-
tions and communication so that HCPs can efficiently
support patient informed choice to promote optimal
adherence both individually and as part of a multidiscip-
linary team. Yet in this study, 53% of CPs cited that
language barrier was a factor hindering them communi-
cating with their patients.
Study limitations
The current study has several limitations that should be
taken into consideration when interpreting the findings.
The study was conducted only within some regions in
London which limits the generalisability of the results on
a national scale. Furthermore, the effect of counselling on
knowledge regarding antibiotic behaviour was only stud-
ied from the responses acquired from the public in de-
prived areas of London. The sample size of those
responses was rather small, thus limiting the generalisa-
tion of the influence of demographic factors, campaign ex-
posure and counselling on antibiotic knowledge and
adherence. On the other hand, although two attempts
were made to boost response rate for CPs’ survey, yet the
response rate obtained was small to be generalizable. In
general, studies employing a self-administered question-
naire have other potential limitations including
non-response bias, recall bias and social desirability bias
due to the nature of the data being self-reported [43, 56].
The cross-sectional nature of the study also highlights that
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the data is collected at one point in time [43]. Despite
these limitations, the current findings provide update
about the public’s knowledge of antibiotic usage and
awareness of AR. Given the global recognition and threat
of AR, a similar study on a national scale in the UK among
the public and CPs is recommended to provide a more
comprehensive and profound insight into the existing sta-
tus pertaining to antibiotic usage and awareness of AR.
Conclusion
The public surveyed still had deficiencies in antibiotic
knowledge, which highlights that there has been no
change in the status quo with respect to awareness of
antibiotic usage and AR even after the implementation
of several awareness campaigns in England, although re-
spondents from affluent areas performed better overall
compared to those in deprived areas. On the other hand,
those who benefited from CP counselling showed a sig-
nificant better knowledge towards prudent antibiotic
usage which highlights the importance of CPs’ counsel-
ling on every antibiotic prescription. In an era where AR
is a ticking time bomb, stringent measures in prescribing
and dispensing antibiotics should be followed, with a
view to making pharmacist counselling on every anti-
biotic prescription compulsory.
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